The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

Background: Delayed chemotherapy-induced nausea and vomiting (CINV) remains a major adverse effect of cancer chemotherapy. We assessed, under current practice patterns, the occurrence and impact on healthcare resource utilization of CINV in patients receiving emetogenic chemotherapy. An additional a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2004-03, Vol.15 (3), p.526-536
Hauptverfasser:	Ihbe-Heffinger, A., Ehlken, B., Bernard, R., Berger, K., Peschel, C., Eichler, H.-G., Deuson, R., Thödtmann, J., Lordick, F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiemetics - economics Antiemetics - therapeutic use Antineoplastic agents Antineoplastic Agents - adverse effects Biological and medical sciences Cancer Care Facilities chemotherapy-induced nausea and vomiting Cost of Illness Cross-Sectional Studies Drug Costs Female Germany Health Care Costs health economics Health Resources - statistics & numerical data healthcare provider healthcare utilization Humans Male Medical sciences Middle Aged Nausea - chemically induced Nausea - drug therapy Nausea - economics Neoplasms - drug therapy Pharmacology. Drug treatments Prospective Studies third party payer Tumors Vomiting - chemically induced Vomiting - drug therapy Vomiting - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!